@pgholam@NeilFlochMD Furthermore, bariatric surgery needs a follow up as well; vitamin suplementations, possible lifelong complications. And, in my point of view, very careful addiction assessment because of the risk of addiction transfer towards alcohol
📜 Preemptive TIPS — Baveno VIII
🗣️ M. Rudler | #EASLCongress
🔬 72h 🪟 is open! Up to 14 d CPC / 7 d CPB — no MELD futility cut-off
💡 pTIPS preferred in AVB from GOV2/IGV1
🍺 Severe AH: No futility criteria if pTIPS criteria met
🧠 Consider LT in refractory OHE after pTIPS
🚨Alert for new research on one of public health's most overlooked measurement problems — and the numbers are hard to ignore. 🚨
Across 182 countries, we examined how each defines a 'standard drink.' The short answer: most don't.
While in Romania today for the Congress of the Romanian Association for Integrated Hepatology, I had the opportunity to speak to @EuronewsRomani1 about the importance of FIB-4 testing for patients with #obesity and #diabetes: https://t.co/siPTlD46gz #livertwitter
Alcohol-related liver disease in the U.S. could be almost three times higher than previously reported, according to a study in @LancetGastroHep. @juanpabloarab
Interested in the most prevalent liver disease ?
Then turn on your speakers and prepare your questions cause you can ask them on 11th of february!
@esbra_society@ISBRAComm
In an @EASLedu & @AASLDtweets masterclass, we discussed between being resilient vs stubborn.
A resilient person focuses on a meaningful goal, and keeps moving forward despite obstacles.
A stubborn person keeps pushing toward an unreachable aim, even when there are better paths.
When I was 20 had just taken my 1st grant-writing masterclass, the key pieces of advice was: ‘Follow the rockstars.’ Fifteen years later, I have the privilege of participating in the EASL–AASLD Masterclass, where many of those very rockstars are now sharing their experience.
The liver meeting is happening and one of the hottest topics are the interférence of AUD and ARLD.
Cannabinoid system may be a therapeutic target for AUD
⬇️ ALD in pts with Cannabis use disorder compared to those without.
Follow @ASRG_Liver for more Alcohol research
Short-term mortality in severe AlcHep remains high! Our systematic review & meta-analysis presented at #TLM25 shows 28d ≈26.8%, 60d ≈35.1%, 90d ≈43.7%!
We need better treatments and faster, standardized care! #LiverTwitter@FcoIdalsoaga@juanpabloarab
🗣️Integrated care of AUD and ALD is 🔑.
One cannot treat ALD without treating the underlying alcohol use.
To learn more about integrated ALD/AUD care and the gold standard of ALD treatment, please read our new 📜, 🔥 off the press!
https://t.co/uRJH2Hrrl4